Literature DB >> 28410147

The roles of microglia/macrophages in tumor progression of brain cancer and metastatic disease.

Shih-Ying Wu1, Kounosuke Watabe2.   

Abstract

Malignant brain tumors and brain metastases are highly aggressive diseases that are often resistant to treatment. Consequently, the current prognosis of patients with brain tumors and metastases is dismal. Activated microglia and macrophages are often observed in close proximity to or within the malignant tumor masses, suggesting that microglia/macrophages play an important role in brain tumor progression. Microglia, being resident macrophages of the central nervous system, form a major component of the brain immune system. They exhibit anti-tumor functions by phagocytosis and the release of cytotoxic factors. However, these microglia/macrophages can be polarized into becoming tumor-supportive and immunosuppressive cells by certain tumor-derived soluble factors, thereby promoting tumor maintenance and progression. The activated microglia/macrophages also participate in the process of tumor angiogenesis, metastasis, dormancy, and relapse. In this review, we discuss the recent literature on the dual roles of microglia/macrophages in brain tumor progression. We have also reviewed the effect of several well-known microglia/macrophages-derived molecules and signals on brain tumor progression and further discussed the potential therapeutic strategies for targeting the pro-tumor and metastatic functions of microglia/macrophages.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28410147      PMCID: PMC5658785          DOI: 10.2741/4573

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  168 in total

1.  Expression of extracellular matrix molecules in brain metastasis.

Authors:  Seiichi Yoshida; Hideaki Takahashi
Journal:  J Surg Oncol       Date:  2009-07-01       Impact factor: 3.454

2.  Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-alpha exposure.

Authors:  K S Mark; D W Miller
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

3.  Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis.

Authors:  A E Juedes; N H Ruddle
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

4.  β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis.

Authors:  F Klemm; A Bleckmann; L Siam; H N Chuang; E Rietkötter; D Behme; M Schulz; M Schaffrinski; S Schindler; L Trümper; F Kramer; T Beissbarth; C Stadelmann; C Binder; T Pukrop
Journal:  Carcinogenesis       Date:  2010-12-20       Impact factor: 4.944

5.  CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs).

Authors:  Janka Held-Feindt; Kirsten Hattermann; Susanne Sebens Müerköster; Hanna Wedderkopp; Friederike Knerlich-Lukoschus; Hendrik Ungefroren; H Maximilian Mehdorn; Rolf Mentlein
Journal:  Exp Cell Res       Date:  2010-02-23       Impact factor: 3.905

6.  Selective uptake of multi-walled carbon nanotubes by tumor macrophages in a murine glioma model.

Authors:  Michelle VanHandel; Darya Alizadeh; Leying Zhang; Babak Kateb; Michael Bronikowski; Harish Manohara; Behnam Badie
Journal:  J Neuroimmunol       Date:  2009-01-31       Impact factor: 3.478

7.  Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas.

Authors:  Michael Platten; Alexandra Kretz; Ulrike Naumann; Steffen Aulwurm; Kensuke Egashira; Stefan Isenmann; Michael Weller
Journal:  Ann Neurol       Date:  2003-09       Impact factor: 10.422

8.  Importance of direct macrophage-tumor cell interaction on progression of human glioma.

Authors:  Yoshihiro Komohara; Hasita Horlad; Koji Ohnishi; Yukio Fujiwara; Bing Bai; Takenobu Nakagawa; Shinya Suzu; Hideo Nakamura; Jun-ichi Kuratsu; Motohiro Takeya
Journal:  Cancer Sci       Date:  2012-10-26       Impact factor: 6.716

9.  Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas.

Authors:  Darya Alizadeh; Leying Zhang; Jungyeon Hwang; Thomas Schluep; Behnam Badie
Journal:  Nanomedicine       Date:  2009-11-05       Impact factor: 5.307

10.  Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomas.

Authors:  A Bleckmann; L Siam; F Klemm; E Rietkötter; Chr Wegner; F Kramer; T Beissbarth; C Binder; Chr Stadelmann; T Pukrop
Journal:  Clin Exp Metastasis       Date:  2012-12-08       Impact factor: 5.150

View more
  45 in total

Review 1.  The Gut-Brain Axis, Paving the Way to Brain Cancer.

Authors:  Ruty Mehrian-Shai; Juergen K V Reichardt; Curtis C Harris; Amos Toren
Journal:  Trends Cancer       Date:  2019-03-16

Review 2.  Improving CNS Delivery to Brain Metastases by Blood-Tumor Barrier Disruption.

Authors:  Samuel A Sprowls; Tasneem A Arsiwala; Jacob R Bumgarner; Neal Shah; Sundus S Lateef; Brooke N Kielkowski; Paul R Lockman
Journal:  Trends Cancer       Date:  2019-07-20

Review 3.  Foe or friend? Janus-faces of the neurovascular unit in the formation of brain metastases.

Authors:  Imola Wilhelm; Csilla Fazakas; Kinga Molnár; Attila G Végh; János Haskó; István A Krizbai
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-18       Impact factor: 6.200

Review 4.  Immunotherapy of Primary Brain Tumors: Facts and Hopes.

Authors:  Robin A Buerki; Zinal S Chheda; Hideho Okada
Journal:  Clin Cancer Res       Date:  2018-06-05       Impact factor: 12.531

5.  The oncometabolite 2-hydroxyglutarate inhibits microglial activation via the AMPK/mTOR/NF-κB pathway.

Authors:  Chao-Jun Han; Ji-Yue Zheng; Lin Sun; Hui-Cui Yang; Zhong-Qiang Cao; Xiao-Hu Zhang; Long-Tai Zheng; Xue-Chu Zhen
Journal:  Acta Pharmacol Sin       Date:  2019-04-23       Impact factor: 6.150

6.  Genetic Hallmarks and Heterogeneity of Glioblastoma in the Single-Cell Omics Era.

Authors:  Andrea Degl'Innocenti; Nicoletta di Leo; Gianni Ciofani
Journal:  Adv Ther (Weinh)       Date:  2019-12-01

Review 7.  Brain metastases: An update on the multi-disciplinary approach of clinical management.

Authors:  D K Mitchell; H J Kwon; P A Kubica; W X Huff; R O'Regan; M Dey
Journal:  Neurochirurgie       Date:  2021-04-14       Impact factor: 1.553

Review 8.  Neuroimmunology of Behavioral Comorbidities Associated With Cancer and Cancer Treatments.

Authors:  Jessica C Santos; Leah M Pyter
Journal:  Front Immunol       Date:  2018-06-07       Impact factor: 7.561

9.  Characterization of Immune Cell Subsets of Tumor Infiltrating Lymphocytes in Brain Metastases.

Authors:  Priyakshi Kalita-de Croft; Haarika Chittoory; Tam H Nguyen; Jodi M Saunus; Woo Gyeong Kim; Amy E McCart Reed; Malcolm Lim; Xavier M De Luca; Kaltin Ferguson; Colleen Niland; Roberta Mazzieri; Riccardo Dolcetti; Peter T Simpson; Sunil R Lakhani
Journal:  Biology (Basel)       Date:  2021-05-11

Review 10.  Conflicting Roles of Connexin43 in Tumor Invasion and Growth in the Central Nervous System.

Authors:  Miaki Uzu; Wun Chey Sin; Ayaka Shimizu; Hiromi Sato
Journal:  Int J Mol Sci       Date:  2018-04-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.